Add BrightSurf on Google Email

Malnutrition during pregnancy increases diabetes incidence

Researchers at the Complexity Science Hub found a significant link between malnutrition during pregnancy and an increased risk of type 2 diabetes. The study analyzed data from over 3.5 million people in Austria and found that men born during severe famine periods had a 78% higher incidence rate of new diabetes cases.

SourceComplexity Science Hub·JournalHeliyon·TypeData/statistical analysis·DateJul 20, 2023

New comprehensive review of biochemical markers of bone fragility in diabetes

A comprehensive review of biochemical markers for bone fragility in diabetes identifies low bone turnover and alterations in bone quality as key factors. The study suggests that glycemic control, AGEs, and serum IGF-1 may have predictive value for fracture risk in patients with diabetes.

SourceInternational Osteoporosis Foundation·JournalThe Journal of Clinical Endocrinology and Metabolism·TypeLiterature review·DateJul 10, 2023

Produce prescription programs for patients with diabetes could save billions in healthcare costs, study shows

A nationwide produce prescription program for patients with diabetes and food insecurity could prevent 296,000 cases of cardiovascular disease and gain 260,000 quality-adjusted life years. The program is estimated to save $39.6 billion in healthcare spending and $4.8 billion in lost productivity costs.

SourceTufts University·JournalJournal of the American Heart Association·DateJul 7, 2023

Specific DNA modifications are linked to certain conditions including breast cancer, type II diabetes and COPD in an epigenetic study of over 18,000 people in Scotland

An epigenetic study of over 18,000 people in Scotland identified associations between certain DNA modifications and increased risks of breast cancer, type II diabetes, and chronic obstructive pulmonary disease (COPD). The findings provide new insights into the underlying mechanisms of these diseases.

SourcePLOS·JournalPLOS Medicine·DateJul 6, 2023

New study shows glutaminase 2 regulates glucose metabolism in pancreatic β-cells

A recent study published in Scientific Reports has uncovered the crucial role of glutaminase 2 in maintaining glucose homeostasis in pancreatic β-cells, particularly under conditions of hyperglycemia. The research team found that impaired GLS2 activity drives the onset of diabetes mellitus by disrupting insulin and glucagon regulation.

SourceChiba University·JournalScientific Reports·TypeExperimental study·DateJul 5, 2023

Supportive communities can help increase breastfeeding rates for moms, MU study finds

A new study from the University of Missouri-Columbia found that supportive communities and education about breastfeeding health benefits can boost breastfeeding rates, particularly in rural areas where it is less common. The study also showed that reduced stigma surrounding breastfeeding occurred with increased community exposure.

SourceUniversity of Missouri-Columbia·JournalPublic Health Nursing·TypeSurvey·DateJul 3, 2023

Metformin's role in preventing metabolic syndrome during androgen deprivation therapy: a Phase II study

A randomized phase II study found that adding metformin to androgen deprivation therapy did not reduce the risk of metabolic syndrome or improve PSA response in patients with advanced prostate cancer. Metformin showed some antitumor effects through mTOR inhibition, but these were not significant.

SourceImpact Journals LLC·JournalOncotarget·TypeRandomized controlled/clinical trial·DateJun 20, 2023

Black patients with plaque build-up in arteries in the legs more likely to have a stroke, heart attack or amputation than white patients

A new study from Keck Medicine of USC reveals significant racial disparities in the diagnosis and treatment of peripheral artery disease (PAD) among Black and white patients. Black patients are nearly 50% less likely to receive vascular interventions, leading to a higher risk of stroke, heart attack, or amputation.

SourceUniversity of Southern California - Health Sciences·JournalAdvances in Therapy·TypeData/statistical analysis·DateJun 13, 2023

UMass Amherst epidemiologist updates and validates ‘gold standard’ of prenatal physical activity tools

A University of Massachusetts Amherst researcher has updated the Pregnancy Physical Activity Questionnaire (PPAQ), a widely used tool for measuring prenatal physical activity. The new PPAQ is considered reliable and valid, providing estimates of physical activity and sedentary behavior in pregnant women.

SourceUniversity of Massachusetts Amherst·JournalAmerican Journal of Epidemiology·TypeData/statistical analysis·DateJun 8, 2023

Does multimorbidity impact chronic disease treatment?

Researchers analyzed data from 120 clinical trials and found no evidence that treatment efficacies differ depending on the number of comorbidities. The study suggests that modest levels of comorbidities do not affect treatment outcomes, providing valuable insights for clinicians to make informed recommendations.

SourcePLOS·JournalPLOS Medicine·TypeMeta-analysis·DateJun 6, 2023

New Penn Medicine study uncovers key details of fat cells, advancing potential treatments for obesity, diabetes

Researchers have unlocked insights into how brown fat tissue can be harnessed to combat obesity and remove glucose from the blood. The study used a cryogenic electron microscope to view mitochondrial uncoupling protein 1 in atomic detail, revealing potential new ways to promote weight loss.

SourceUniversity of Pennsylvania School of Medicine·JournalScience Advances·TypeObservational study·DateMay 31, 2023

Too few primary care doctors address obesity with their patients, highlighting need for weight loss tool

A new weight loss tool called PATHWEIGH was developed to address clinician barriers in providing patient care that addresses weight. The tool has shown early success and has been implemented in a health system's primary care clinics, improving weight management efforts among patients with obesity.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateMay 23, 2023

Wakefulness-promoting agents effective for excessive daytime sleepiness but patients may discontinue due to side effects

Researchers found that solriamfetol, armodafinil–modafinil, and pitolisant reduce excessive daytime sleepiness in patients with obstructive sleep apnea already using conventional therapy. However, patients may be more likely to discontinue the use of these medications due to adverse events including headache, anxiety, and insomnia.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeLiterature review·DateMay 8, 2023

Neuropathic pain: The underlying mechanism and a potential therapeutic target are revealed in mice

Researchers uncover a pathophysiological mechanism that initiates and sustains neuropathic pain in mice, identifying Tiam1 as a potential therapeutic target. Targeting spinal Tiam1 with antisense oligonucleotides alleviates neuropathic pain hypersensitivity, offering promise for treating chronic pain.

SourceUniversity of Alabama at Birmingham·JournalNeuron·TypeExperimental study·DateMay 4, 2023

Pioneering MRI imaging method captures brain glucose metabolism without the need for administration of radioactive substances

A new MRI approach uses harmless glucose solution to map brain glucose metabolism, generating reliable results and potentially improving diagnosis of conditions like Alzheimer's and cancer. Further studies are needed to confirm the findings and deploy this less-invasive method for patients.

SourceMedical University of Vienna·JournalNature Biomedical Engineering·DateApr 28, 2023

Study unlocks potential breakthrough in Type 1 diabetes treatment

Rice University scientists developed a screening technique to identify high-performing biomaterials for encapsulating insulin-secreting cells, providing long-term blood sugar level control in diabetic mice. The study's findings have the potential to open the door to a more sustainable and self-regulating way to treat Type 1 diabetes.

SourceRice University·JournalNature Biomedical Engineering·TypeExperimental study·DateApr 27, 2023

Maynooth University study finds the metabolic regulator MYC is defective in obesity

A Maynooth University study published in Science Signaling has found that the MYC protein is essential for MAIT cell growth, proliferation, metabolism, and function. The researchers also discovered that MYC is defective in people with obesity, providing a mechanism to explain why MAIT cells are impaired in this condition.

SourceMaynooth University·JournalScience Signaling·TypeExperimental study·DateApr 27, 2023

Achieving prevention and health, rather than more healthcare

Researchers found deaths from gallstone disease increased in younger populations and those with Medicaid after Medicaid expansion, highlighting the need for proactive prevention over reactive emergency care. A new healthcare model emphasizing primary care and prevention is proposed to address these inequities.

SourceRutgers University·JournalJournal of Surgical Research·TypeData/statistical analysis·DateApr 23, 2023

Sugar-sweetened beverages linked with increased risk of premature death for people with type 2 diabetes

A new study found that high consumption of sugar-sweetened beverages was associated with an elevated risk of premature death and incidence of cardiovascular disease among people with type 2 diabetes. Drinking healthier beverages like coffee, tea, and plain water was linked to lower risk of dying prematurely.

SourceHarvard T.H. Chan School of Public Health·JournalThe BMJ·TypeObservational study·DateApr 19, 2023

Machine-learning technique identifies people who would benefit most from treatment to reduce future cardiovascular disease risk

Researchers used a novel machine-learning technique called causal forest, which found that treating individuals with high estimated benefits provided better population health outcomes than the traditional high-risk approach. This approach targets those with high blood pressure and could lead to more effective treatment strategies.

SourceUniversity of California - Los Angeles Health Sciences·JournalInternational Journal of Epidemiology·TypeData/statistical analysis·DateApr 14, 2023